See more : Kuobrothers Corp. (8477.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of CONMED Corporation (CNMD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CONMED Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Hospital Corporation of China Limited (3869.HK) Income Statement Analysis – Financial Results
- Ramelius Resources Limited (RMS.AX) Income Statement Analysis – Financial Results
- The Tel-Aviv Stock Exchange Ltd. (TASE.TA) Income Statement Analysis – Financial Results
- NP3 Fastigheter AB (publ) (NP3-PREF.ST) Income Statement Analysis – Financial Results
- Mitsubishi Chemical Group Corporation (4188.T) Income Statement Analysis – Financial Results
CONMED Corporation (CNMD)
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.24B | 1.05B | 1.01B | 862.46M | 955.10M | 859.63M | 796.39M | 763.52M | 719.17M | 734.47M | 756.76M | 767.14M | 725.08M | 713.72M | 694.74M | 742.18M | 694.29M | 646.81M | 617.31M | 558.39M | 497.13M | 453.06M | 428.72M | 392.23M | 372.60M | 336.40M | 138.30M | 125.60M | 99.60M | 71.10M | 53.60M | 42.60M | 38.50M | 31.40M | 19.90M | 14.20M | 12.50M | 10.50M |
| Cost of Revenue | 568.50M | 474.23M | 442.60M | 402.16M | 430.38M | 390.52M | 365.35M | 355.19M | 337.47M | 336.00M | 350.29M | 361.30M | 350.14M | 348.34M | 357.41M | 359.80M | 345.16M | 333.97M | 304.28M | 271.50M | 237.43M | 215.89M | 204.37M | 158.74M | 152.80M | 146.00M | 67.20M | 59.00M | 47.40M | 34.90M | 26.90M | 20.30M | 18.40M | 15.30M | 11.70M | 7.50M | 6.40M | 5.50M |
| Gross Profit | 676.25M | 571.25M | 568.04M | 460.30M | 524.72M | 469.11M | 431.04M | 408.33M | 381.70M | 398.47M | 406.47M | 405.84M | 374.93M | 365.38M | 337.33M | 382.38M | 349.13M | 312.85M | 313.02M | 286.89M | 259.70M | 237.17M | 224.35M | 233.49M | 219.80M | 190.40M | 71.10M | 66.60M | 52.20M | 36.20M | 26.70M | 22.30M | 20.10M | 16.10M | 8.20M | 6.70M | 6.10M | 5.00M |
| Gross Profit Ratio | 54.33% | 54.64% | 56.21% | 53.37% | 54.94% | 54.57% | 54.12% | 53.48% | 53.08% | 54.25% | 53.71% | 52.90% | 51.71% | 51.19% | 48.56% | 51.52% | 50.29% | 48.37% | 50.71% | 51.38% | 52.24% | 52.35% | 52.33% | 59.53% | 58.99% | 56.60% | 51.41% | 53.03% | 52.41% | 50.91% | 49.81% | 52.35% | 52.21% | 51.27% | 41.21% | 47.18% | 48.80% | 47.62% |
| Research & Development | 52.60M | 47.15M | 43.57M | 40.47M | 45.46M | 42.19M | 32.31M | 32.25M | 27.44M | 27.78M | 25.83M | 28.21M | 28.65M | 29.65M | 31.84M | 33.11M | 30.40M | 30.72M | 25.47M | 20.21M | 17.31M | 16.09M | 14.83M | 14.87M | 12.10M | 12.00M | 3.00M | 3.00M | 2.80M | 2.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 400.14M | 355.62M | 351.80M | 338.40M | 303.09M | 293.94M | 310.73M | 302.47M | 277.71M | 276.46M | 266.31M | 272.44M | 240.54M | 234.83M | 216.69M | 183.18M | 157.45M | 141.74M | 140.56M | 124.67M | 107.20M | 93.60M | 35.30M | 31.60M | 25.60M | 21.00M | 25.30M | 14.30M | 11.90M | 10.10M | 6.90M | 5.00M | 3.90M | 3.30M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 504.71M | 454.04M | 414.75M | 373.82M | 400.14M | 355.62M | 351.80M | 338.40M | 303.09M | 293.94M | 310.73M | 302.47M | 277.71M | 276.46M | 266.31M | 272.44M | 240.54M | 234.83M | 216.69M | 183.18M | 157.45M | 141.74M | 140.56M | 124.67M | 107.20M | 93.60M | 35.30M | 31.60M | 25.60M | 21.00M | 25.30M | 14.30M | 11.90M | 10.10M | 6.90M | 5.00M | 3.90M | 3.30M |
| Other Expenses | 0.00 | -112.01M | -1.13M | -355.00K | -5.19M | 0.00 | 0.00 | -2.94M | 0.00 | 7.32M | 8.75M | 7.20M | 0.00 | 2.18M | 10.92M | 1.58M | -4.63M | 51.90M | 7.12M | 20.34M | -2.92M | 0.00 | 0.00 | 29.49M | 25.70M | 23.60M | 7.00M | 6.40M | 0.00 | 3.90M | 3.30M | 2.20M | 2.10M | 1.60M | 1.00M | 600.00K | 400.00K | 300.00K |
| Operating Expenses | 555.64M | 501.19M | 458.32M | 414.29M | 445.60M | 397.81M | 384.11M | 370.65M | 330.53M | 345.68M | 349.96M | 340.63M | 306.36M | 308.29M | 309.06M | 307.12M | 266.31M | 317.45M | 249.27M | 223.73M | 171.84M | 157.82M | 155.39M | 169.03M | 145.00M | 129.20M | 45.30M | 41.00M | 33.40M | 27.30M | 28.60M | 16.50M | 14.00M | 11.70M | 7.90M | 5.60M | 4.30M | 3.60M |
| Cost & Expenses | 1.12B | 975.42M | 900.92M | 816.45M | 875.98M | 788.33M | 749.46M | 725.84M | 667.99M | 681.68M | 700.25M | 701.93M | 656.50M | 656.63M | 666.47M | 666.92M | 611.48M | 651.42M | 553.56M | 495.23M | 409.28M | 373.71M | 359.76M | 327.77M | 297.80M | 275.20M | 112.50M | 100.00M | 80.80M | 62.20M | 55.50M | 36.80M | 32.40M | 27.00M | 19.60M | 13.10M | 10.70M | 9.10M |
| Interest Income | 0.00 | 28.91M | 35.49M | 44.05M | 42.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 39.78M | 28.91M | 35.49M | 44.05M | 42.70M | 20.65M | 18.20M | 15.36M | 6.03M | 6.11M | 5.61M | 5.73M | 6.68M | 7.11M | 7.09M | 10.37M | 16.23M | 19.12M | 15.58M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 51.40M | 49.76M | 49.79M | 52.24M | 50.99M | 61.80M | 58.55M | 55.31M | 43.88M | 45.73M | 47.87M | 46.62M | 42.69M | 41.81M | 41.28M | 32.34M | 31.53M | 29.85M | 30.79M | 26.87M | 24.85M | 22.37M | 30.15M | 29.49M | 25.70M | 23.60M | 7.00M | 6.40M | 5.00M | 3.90M | 3.30M | 2.20M | 2.10M | 1.60M | 1.00M | 600.00K | 400.00K | 300.00K |
| EBITDA | 192.48M | 7.80M | 158.38M | 113.58M | 124.91M | 133.11M | 105.48M | 90.04M | 95.05M | 98.52M | 104.11M | 111.83M | 47.06M | 94.58M | 66.52M | 111.97M | 112.53M | 25.25M | 94.53M | 89.20M | 112.71M | 101.72M | 99.11M | 93.95M | 100.50M | 84.80M | 32.80M | 32.00M | 23.80M | 12.80M | 1.40M | 8.00M | 8.20M | 6.00M | 1.30M | 1.70M | 2.20M | 1.70M |
| EBITDA Ratio | 15.46% | -4.01% | 10.74% | 5.29% | 7.74% | 8.29% | 5.89% | 11.79% | 13.22% | 13.41% | 13.79% | 14.58% | 15.34% | 13.86% | 10.01% | 14.50% | 16.07% | 12.03% | 16.47% | 19.91% | 25.30% | 22.45% | 23.12% | 23.95% | 26.97% | 25.21% | 50.04% | 25.48% | 23.90% | 18.00% | 2.99% | 18.08% | 20.52% | 19.11% | 6.03% | 10.56% | 16.80% | 16.19% |
| Operating Income | 130.79M | 70.05M | 37.85M | -26.97M | 1.60M | 71.31M | 46.94M | 37.68M | 51.18M | 52.79M | 56.51M | 65.21M | 8.27M | 57.09M | 28.27M | 75.26M | 80.99M | -4.60M | 63.75M | 63.16M | 79.96M | 79.35M | 68.96M | 64.46M | 74.80M | 61.20M | 25.80M | 25.60M | 18.80M | 8.90M | -1.90M | 5.80M | 6.10M | 4.40M | 300.00K | 1.10M | 1.80M | 1.40M |
| Operating Income Ratio | 10.51% | 6.70% | 3.74% | -3.13% | 0.17% | 8.29% | 5.89% | 4.93% | 7.12% | 7.19% | 7.47% | 8.50% | 1.14% | 8.00% | 4.07% | 10.14% | 11.67% | -0.71% | 10.33% | 11.31% | 16.08% | 17.51% | 16.08% | 16.44% | 20.08% | 18.19% | 18.66% | 20.38% | 18.88% | 12.52% | -3.54% | 13.62% | 15.84% | 14.01% | 1.51% | 7.75% | 14.40% | 13.33% |
| Total Other Income/Expenses | -49.96M | -140.92M | -36.61M | -44.41M | -47.89M | -20.65M | -18.20M | -18.30M | -6.03M | -6.11M | -5.88M | -5.73M | -59.40M | -11.44M | -10.11M | -6.00M | -13.43M | -19.80M | -15.58M | -13.60M | -26.95M | -25.99M | -30.82M | -34.29M | -32.30M | -30.90M | -36.50M | -100.00K | -2.00M | -600.00K | -200.00K | 300.00K | -200.00K | -700.00K | -100.00K | 100.00K | 0.00 | -200.00K |
| Income Before Tax | 80.83M | -70.86M | 73.11M | 1.60M | 31.23M | 50.65M | 28.73M | 19.38M | 45.14M | 46.68M | 50.63M | 59.48M | -2.31M | 45.66M | 18.16M | 69.26M | 64.76M | -24.40M | 48.17M | 49.56M | 53.01M | 54.84M | 38.13M | 30.18M | 42.50M | 30.30M | -10.70M | 25.50M | 16.80M | 8.30M | -2.10M | 6.10M | 5.90M | 3.70M | 200.00K | 1.20M | 1.80M | 1.20M |
| Income Before Tax Ratio | 6.49% | -6.78% | 7.23% | 0.19% | 3.27% | 5.89% | 3.61% | 2.54% | 6.28% | 6.35% | 6.69% | 7.75% | -0.32% | 6.40% | 2.61% | 9.33% | 9.33% | -3.77% | 7.80% | 8.88% | 10.66% | 12.10% | 8.89% | 7.69% | 11.41% | 9.01% | -7.74% | 20.30% | 16.87% | 11.67% | -3.92% | 14.32% | 15.32% | 11.78% | 1.01% | 8.45% | 14.40% | 11.43% |
| Income Tax Expense | 16.37M | 9.72M | 10.56M | -7.91M | 2.61M | 9.80M | -26.76M | 4.71M | 14.65M | 14.48M | 14.69M | 19.00M | -3.06M | 15.31M | 6.02M | 24.70M | 23.30M | -11.89M | 16.18M | 16.10M | 20.93M | 19.74M | 13.73M | 10.86M | 15.30M | 10.90M | -3.60M | 9.20M | 5.90M | 2.90M | -700.00K | 2.00M | 2.00M | 1.30M | 100.00K | 400.00K | 700.00K | 500.00K |
| Net Income | 64.46M | -80.58M | 62.54M | 9.52M | 28.62M | 40.85M | 55.49M | 14.66M | 30.50M | 32.19M | 35.94M | 40.48M | 752.00K | 30.35M | 12.14M | 44.56M | 41.46M | -12.51M | 31.99M | 33.47M | 32.08M | 34.15M | 24.41M | 19.31M | 27.20M | 17.80M | -7.10M | 16.30M | 10.90M | 5.40M | -1.40M | 4.10M | 3.90M | 2.40M | -300.00K | 800.00K | 1.10M | 700.00K |
| Net Income Ratio | 5.18% | -7.71% | 6.19% | 1.10% | 3.00% | 4.75% | 6.97% | 1.92% | 4.24% | 4.38% | 4.75% | 5.28% | 0.10% | 4.25% | 1.75% | 6.00% | 5.97% | -1.93% | 5.18% | 5.99% | 6.45% | 7.54% | 5.69% | 4.92% | 7.30% | 5.29% | -5.13% | 12.98% | 10.94% | 7.59% | -2.61% | 9.62% | 10.13% | 7.64% | -1.51% | 5.63% | 8.80% | 6.67% |
| EPS | 2.10 | -2.68 | 2.14 | 0.33 | 1.01 | 1.45 | 1.99 | 0.53 | 1.10 | 1.17 | 1.30 | 1.43 | 0.03 | 1.06 | 0.42 | 1.55 | 1.46 | -0.45 | 1.09 | 1.13 | 1.11 | 1.25 | 1.02 | 0.84 | 1.19 | 0.79 | -0.31 | 0.77 | 0.64 | 0.40 | -0.11 | 0.28 | 0.31 | 0.25 | -0.03 | 0.08 | 0.14 | 0.10 |
| EPS Diluted | 2.04 | -2.68 | 1.94 | 0.32 | 0.97 | 1.41 | 1.97 | 0.52 | 1.09 | 1.16 | 1.28 | 1.41 | 0.03 | 1.05 | 0.42 | 1.52 | 1.43 | -0.45 | 1.08 | 1.11 | 1.10 | 1.23 | 1.00 | 0.83 | 1.17 | 0.77 | -0.31 | 0.75 | 0.63 | 0.37 | -0.11 | 0.28 | 0.31 | 0.25 | -0.03 | 0.08 | 0.14 | 0.10 |
| Weighted Avg Shares Out | 30.67M | 30.04M | 29.16M | 28.58M | 28.33M | 28.12M | 27.94M | 27.80M | 27.65M | 27.40M | 27.72M | 28.30M | 28.25M | 28.72M | 29.07M | 28.80M | 28.39M | 27.79M | 29.35M | 29.62M | 28.90M | 27.32M | 23.93M | 22.99M | 22.91M | 22.63M | 22.65M | 21.07M | 17.04M | 13.49M | 13.12M | 14.64M | 12.71M | 9.72M | 11.24M | 10.00M | 7.85M | 7.00M |
| Weighted Avg Shares Out (Dil) | 31.55M | 30.04M | 32.22M | 29.46M | 29.50M | 28.89M | 28.17M | 27.96M | 27.86M | 27.77M | 28.11M | 28.65M | 28.63M | 28.91M | 29.14M | 29.23M | 28.99M | 27.79M | 29.62M | 30.15M | 29.17M | 27.77M | 24.41M | 23.27M | 23.17M | 23.02M | 22.65M | 21.82M | 17.42M | 14.46M | 13.12M | 14.64M | 12.71M | 9.72M | 11.24M | 10.00M | 7.85M | 7.00M |
Conmed (CNMD) Surpasses Q2 Earnings and Revenue Estimates
Conmed (CNMD) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.76 per share a year ago.
CONMED Corporation Announces Second Quarter 2023 Financial Results
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights Sales of $317.7 million increased 14.6% year over year as reported and 16.6% in constant currency. Acquisitions contributed...
Here's Why You Should Retain CONMED (CNMD) Stock for Now
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
Are You Looking for a Top Momentum Pick? Why Conmed (CNMD) is a Great Choice
Does Conmed (CNMD) have what it takes to be a top stock pick for momentum investors? Let's find out.
CONMED (CNMD) Stock Hits 52-Week High: Will It Continue?
CONMED (CNMD) continues to raise optimism in investors due to its broad product spectrum.
CONMED Corporation to Participate in a Fireside Chat at the Jefferies Healthcare Conference
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the...
PDCO or CNMD: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Dental Supplies stocks are likely familiar with Patterson Cos. (PDCO) and Conmed (CNMD).
Here's Why You Should Retain CONMED (CNMD) Stock for Now
Investors continue to be optimistic about CONMED (CNMD) owing to its broad product spectrum.
CONMED (CNMD) Beats on Q1 Earnings, Ups '23 EPS View
CONMED's (CNMD) adjusted first-quarter sales and earnings recover from the disruption in the fourth quarter due to implementation of a new warehouse management system.
CONMED Corporation (CNMD) Q1 2023 Earnings Call Transcript
CONMED Corporation (CNMD) Q1 2023 Earnings Call Transcript.
Source: https://incomestatements.info
Category: Stock Reports